Table of Contents
Epilepsy Research and Treatment
Volume 2016 (2016), Article ID 1435150, 5 pages
http://dx.doi.org/10.1155/2016/1435150
Research Article

Juvenile Myoclonic Epilepsy in Rural Western India: Not Yet a Benign Syndrome

1Department of Medicine, Pramukhswami Medical College, Shree Krishna Hospital, Karamsad, Anand, Gujarat 388325, India
2Department of Neurology, Pramukhswami Medical College, Shree Krishna Hospital, Karamsad, Anand, Gujarat 388325, India

Received 20 April 2016; Revised 30 August 2016; Accepted 27 September 2016

Academic Editor: Morten I. Lossius

Copyright © 2016 Devangi Desai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Commission on Classification and Terminology of the International League Against Epilepsy, “Proposal for revised classification of epilepsies and epileptic syndromes,” Epilepsia, vol. 30, no. 4, pp. 389–399, 1989. View at Publisher · View at Google Scholar
  2. D. Janz and W. Christian, “Impulsiv petit mal,” Deutsche Zeitschrift für Nervenheilkunde, vol. 176, pp. 346–386, 1957, English Translation by P. Genton in Idiopathic Generalized Epilepsies, A. Malafosse, P. Genton, E. Hirsch, C. Marescaux, D. Broglin, M. Bernasconi, Eds., John Libbey, London, UK, pp. 229–251, 1994 View at Google Scholar
  3. P. Genton and P. Gelisse, “The history of juvenile myoclonic epilepsy,” Epilepsy and Behavior, vol. 28, no. 1, pp. S2–S7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. D. G. A. Kasteleijn- Nolst Trenité, B. Schmitz, D. Janz et al., “Consensus on diagnosis and management of JME: from founder's observations to current trends,” Epilepsy and Behavior, vol. 28, no. 1, pp. S87–S90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Baykan, I. E. Martínez-Juárez, E. A. Altindag, C. S. Camfield, and P. R. Camfield, “Lifetime prognosis of juvenile myoclonic epilepsy,” Epilepsy and Behavior, vol. 28, supplement 1, pp. S18–S24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. S. Camfield and P. R. Camfield, “Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study,” Neurology, vol. 73, no. 13, pp. 1041–1045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Grünewald, E. Chroni, and C. P. Panayiotopoulos, “Delayed diagnosis of juvenile myoclonic epilepsy,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 6, pp. 497–499, 1992. View at Publisher · View at Google Scholar · View at Scopus
  8. C. P. Panayiotopoulos, A. R. Tahan, and T. Obeid, “Juvenile myoclonic epilepsy: factors of error involved in the diagnosis and treatment,” Epilepsia, vol. 32, no. 5, pp. 672–676, 1991. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Vijai, P. J. Cherian, P. N. Sylaja, A. Anand, and K. Radhakrishnan, “Clinical characteristics of a South Indian cohort of juvenile myoclonic epilepsy probands,” Seizure, vol. 12, no. 7, pp. 490–496, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Kivity and E. Rechtman, “Juvenile myoclonic epilepsy: serious consequences due to pitfalls in diagnosis and management,” Epilepsia, vol. 36, supplement 3, article 66, 1995. View at Google Scholar
  11. D. Desai, S. Desai, and T. Jani, “Study of prevalence of uncontrolled seizures in patients with juvenile myoclonic epilepsy and its responsible factors in a rural based neurology clinic in Western India,” in Proceedings of the 10th Asia-Oceanian Epilepsy Congress, pp. 143–161, 2014.
  12. B. Baykan, E. A. Altindag, N. Bebek et al., “Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy,” Neurology, vol. 70, no. 22, pp. 2123–2129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. S. Jayalakshmi, B. Srinivasa Rao, and S. Sailaja, “Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy,” Acta Neurologica Scandinavica, vol. 122, no. 2, pp. 115–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. D. T. Sözüer, D. Atakli, T. Atay, S. Baybas, and B. Arpaci, “Evaluation of various antiepileptic drugs in juvenile myoclonic epilepsy,” Epilepsia, vol. 37, supplement 4, p. 77, 1996. View at Google Scholar
  15. P. Genton, P. Gelisse, P. Thomas, and C. Dravet, “Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?” Neurology, vol. 55, no. 8, pp. 1106–1109, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Jayalakshmi, G. Padmaja, S. Vooturi, A. Bogaraju, and M. Surath, “Impact of family support on psychiatric disorders and seizure control in patients with juvenile myoclonic epilepsy,” Epilepsy and Behavior, vol. 37, pp. 7–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. J. Wilson, P. Bladin, and M. Saling, “The ‘burden of normality’: concepts of adjustment after surgery for seizures,” Journal of Neurology Neurosurgery and Psychiatry, vol. 70, no. 5, pp. 649–656, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Geithner, F. Schneider, Z. Wang et al., “Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25–63 years of follow-up,” Epilepsia, vol. 53, no. 8, pp. 1379–1386, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Senf, B. Schmitz, M. Holtkamp, and D. Janz, “Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors,” Neurology, vol. 81, no. 24, pp. 2128–2133, 2013. View at Publisher · View at Google Scholar · View at Scopus